Levofloxacin: Insights Into Antibiotic Resistance and Product Quality

Area of Science:

• Pharmaceutical Sciences
• Public Health
• Medicinal Chemistry

Background:

• Counterfeit and substandard medicines pose significant public health risks.
• Compromised antibacterial medicine quality can impede patient recovery and foster antimicrobial resistance.
• Levofloxacin quality is critical for therapeutic success, with substandard raw materials causing treatment failure.

Purpose of the Study:

• To summarize issues and risk factors associated with low-quality levofloxacin.
• To identify key product quality aspects requiring strict regulation.
• To aid in improving drug quality in developing countries and reducing treatment failures.

Main Methods:

• Review of existing literature on substandard levofloxacin.
• Analysis of factors contributing to poor drug quality, including raw material issues.
• Discussion of quality control methods like dissolution testing and general quality-testing procedures.

Main Results:

• Poor quality of the active ingredient (levofloxacin) leads to insufficient dosage, mislabeling, and poor dissolution.
• These quality defects result in reduced bioavailability and treatment failure.
• Identifying and reporting these factors can guide regulatory improvements.

Conclusions:

• Strict regulation of levofloxacin product quality is essential.
• Enhanced quality control measures, including dissolution testing, are vital for ensuring drug efficacy.
• Addressing substandard medicines can improve patient outcomes and combat antimicrobial resistance.